165 related articles for article (PubMed ID: 30399139)
1. Isoform 6-selective histone deacetylase inhibition reduces lesion size and brain swelling following traumatic brain injury and hemorrhagic shock.
Nikolian VC; Dennahy IS; Weykamp M; Williams AM; Bhatti UF; Eidy H; Ghandour MH; Chtraklin K; Li Y; Alam HB
J Trauma Acute Care Surg; 2019 Feb; 86(2):232-239. PubMed ID: 30399139
[TBL] [Abstract][Full Text] [Related]
2. Addition of low-dose valproic acid to saline resuscitation provides neuroprotection and improves long-term outcomes in a large animal model of combined traumatic brain injury and hemorrhagic shock.
Halaweish I; Bambakidis T; Chang Z; Wei H; Liu B; Li Y; Bonthrone T; Srinivasan A; Bonham T; Chtraklin K; Alam HB
J Trauma Acute Care Surg; 2015 Dec; 79(6):911-9; discussion 919. PubMed ID: 26680134
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 6 inhibition improves survival in a swine model of lethal hemorrhage, polytrauma, and bacteremia.
Biesterveld BE; Wakam GK; Kemp MT; Williams AM; Shamshad A; O'Connell RL; Siddiqui AZ; Chtraklin K; Bhatti UF; Li Y; Alam HB
J Trauma Acute Care Surg; 2020 Nov; 89(5):932-939. PubMed ID: 32195993
[TBL] [Abstract][Full Text] [Related]
4. Valproic Acid and Neural Apoptosis, Inflammation, and Degeneration 30 Days after Traumatic Brain Injury, Hemorrhagic Shock, and Polytrauma in a Swine Model.
Chang P; Williams AM; Bhatti UF; Biesterveld BE; Liu B; Nikolian VC; Dennahy IS; Lee J; Li Y; Alam HB
J Am Coll Surg; 2019 Mar; 228(3):265-275. PubMed ID: 30639301
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury.
Jin G; Duggan M; Imam A; Demoya MA; Sillesen M; Hwabejire J; Jepsen CH; Liu B; Mejaddam AY; Lu J; Smith WM; Velmahos GC; Socrate S; Alam HB
J Trauma Acute Care Surg; 2012 Dec; 73(6):1461-70. PubMed ID: 23188239
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock.
Dekker SE; Sillesen M; Bambakidis T; Andjelkovic AV; Jin G; Liu B; Boer C; Johansson PI; Linzel D; Halaweish I; Alam HB
J Surg Res; 2014 Jul; 190(1):312-8. PubMed ID: 24694719
[TBL] [Abstract][Full Text] [Related]
7. Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injury.
Wakam GK; Biesterveld BE; Pai MP; Kemp MT; O'Connell RL; Williams AM; Srinivasan A; Chtraklin K; Siddiqui AZ; Bhatti UF; Vercruysse CA; Alam HB
J Trauma Acute Care Surg; 2021 Feb; 90(2):346-352. PubMed ID: 33230090
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma.
Nikolian VC; Georgoff PE; Pai MP; Dennahy IS; Chtraklin K; Eidy H; Ghandour MH; Han Y; Srinivasan A; Li Y; Alam HB
J Trauma Acute Care Surg; 2017 Dec; 83(6):1066-1073. PubMed ID: 28697014
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic modulation of brain metabolism by valproic acid can induce a neuroprotective environment.
Bhatti UF; Karnovsky A; Dennahy IS; Kachman M; Williams AM; Nikolian VC; Biesterveld BE; Siddiqui A; O'Connell RL; Liu B; Li Y; Alam HB
J Trauma Acute Care Surg; 2021 Mar; 90(3):507-514. PubMed ID: 33196629
[TBL] [Abstract][Full Text] [Related]
10. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
[TBL] [Abstract][Full Text] [Related]
11. Rapid valproic acid-induced modulation of the traumatic proteome in a porcine model of traumatic brain injury and hemorrhagic shock.
Weykamp M; Nikolian VC; Dennahy IS; Higgins GA; Georgoff PE; Remmer H; Ghandour MH; Alam HB
J Surg Res; 2018 Aug; 228():84-92. PubMed ID: 29907235
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel neuroprotective strategy: combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells.
Jin G; Liu B; You Z; Bambakidis T; Dekker SE; Maxwell J; Halaweish I; Linzel D; Alam HB
Surgery; 2014 Aug; 156(2):221-8. PubMed ID: 24950983
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
Butt MU; Sailhamer EA; Li Y; Liu B; Shuja F; Velmahos GC; DeMoya M; King DR; Alam HB
J Surg Res; 2009 Oct; 156(2):290-6. PubMed ID: 19665733
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid treatment rescues injured tissues after traumatic brain injury.
Biesterveld BE; Pumiglia L; Iancu A; Shamshad AA; Remmer HA; Siddiqui AZ; O'Connell RL; Wakam GK; Kemp MT; Williams AM; Pai MP; Alam HB
J Trauma Acute Care Surg; 2020 Dec; 89(6):1156-1165. PubMed ID: 32890344
[TBL] [Abstract][Full Text] [Related]
16. Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury.
Lin CF; Hsu KC; HuangFu WC; Lin TE; Huang HL; Pan SL
BMC Pharmacol Toxicol; 2020 Mar; 21(1):21. PubMed ID: 32178737
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock.
Imam AM; Jin G; Duggan M; Sillesen M; Hwabejire JO; Jepsen CH; DePeralta D; Liu B; Lu J; deMoya MA; Socrate S; Alam HB
Surgery; 2013 Aug; 154(2):388-96. PubMed ID: 23889966
[TBL] [Abstract][Full Text] [Related]
18. Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage.
Dekker SE; Bambakidis T; Sillesen M; Liu B; Johnson CN; Jin G; Li Y; Alam HB
J Trauma Acute Care Surg; 2014 Dec; 77(6):906-12; discussion 912. PubMed ID: 25051383
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway.
Zhang WB; Zhang HY; Jiao FZ; Wang LW; Zhang H; Gong ZJ
Biomed Pharmacother; 2018 Jan; 97():818-824. PubMed ID: 29112935
[TBL] [Abstract][Full Text] [Related]
20. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
